TRANSCUTANEOUS DOSAGE FORMULATION
    8.
    发明公开
    TRANSCUTANEOUS DOSAGE FORMULATION 审中-公开
    经皮给药剂型

    公开(公告)号:EP2964257A1

    公开(公告)日:2016-01-13

    申请号:EP14759477.4

    申请日:2014-03-10

    摘要: Provided are topical delivery systems and methods for treating and/or preventing a disease or disorder in a subject, or for eliciting an immune response in a subject, including applying, to at least a portion of the subject's post-auricular region, a topical delivery system including a therapeutically effective amount of a topical pharmaceutical composition comprising at least one active agent and a pharmaceutically acceptable carrier and/or adjuvant. The topical pharmaceutical composition can include a topical immunogenic composition. The topical delivery system can further include a flexible substrate in communication with the topical immunogenic composition. The subject can be a pediatric subject.

    摘要翻译: 提供用于治疗和/或预防受试者的疾病或病症或用于在受试者中引起免疫应答的局部递送系统和方法,包括向受试者的耳后区的至少一部分施用局部递送 系统,其包括治疗有效量的包含至少一种活性剂和药学上可接受的载体和/或佐剂的局部药物组合物。 局部药物组合物可以包含局部免疫原性组合物。 局部递送系统可以进一步包括与局部免疫原性组合物连通的柔性基底。 受试者可以是儿科患者。